239 related articles for article (PubMed ID: 26857319)
1. Analysis of histopathological aspects and bone destruction characteristics in acquired middle ear cholesteatoma of pediatric and adult patients.
Aslıer M; Erdag TK; Sarioglu S; Güneri EA; Ikiz AO; Uzun E; Özer E
Int J Pediatr Otorhinolaryngol; 2016 Mar; 82():73-7. PubMed ID: 26857319
[TBL] [Abstract][Full Text] [Related]
2. [Is reuse of autologous ear ossicles in cholesteatoma or chronic suppurative otitis media justified?].
Peng JC; Hoppe F
Laryngorhinootologie; 1994 Jul; 73(7):375-80. PubMed ID: 7916783
[TBL] [Abstract][Full Text] [Related]
3. Cathepsin L activity and its inhibitor in human otitis media.
Kusunoki T; Nishida S; Murata K; Kobashi K; Nakatani H; Hiwasa T; Tomura T
J Otolaryngol; 2001 Jun; 30(3):157-61. PubMed ID: 11771045
[TBL] [Abstract][Full Text] [Related]
4. Aggressiveness and quantification of epithelial proliferation of middle ear cholesteatoma by MIB1.
Mallet Y; Nouwen J; Lecomte-Houcke M; Desaulty A
Laryngoscope; 2003 Feb; 113(2):328-31. PubMed ID: 12567091
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of epithelial proliferation in paediatric and adult cholesteatomas using the Ki-67 proliferation marker.
Sikka K; Sharma SC; Thakar A; Dattagupta S
J Laryngol Otol; 2012 May; 126(5):460-3. PubMed ID: 22166746
[TBL] [Abstract][Full Text] [Related]
6. Clinical and biochemical studies of bone destruction in cholesteatoma.
Amar MS; Wishahi HF; Zakhary MM
J Laryngol Otol; 1996 Jun; 110(6):534-9. PubMed ID: 8763371
[TBL] [Abstract][Full Text] [Related]
7. Involvement of interleukin-1 in middle ear cholesteatoma.
Shiwa M; Kojima H; Kamide Y; Moriyama H
Am J Otolaryngol; 1995; 16(5):319-24. PubMed ID: 7503375
[TBL] [Abstract][Full Text] [Related]
8. Histological Changes of the Middle Ear Ossicles Harvested during Cholesteatoma Surgery.
Školoudík L; Šimáková E; Kalfeřt D; Chrobok V
Acta Medica (Hradec Kralove); 2015; 58(4):119-22. PubMed ID: 26960823
[TBL] [Abstract][Full Text] [Related]
9. [Molecular control of bone resorption in chronic otitis media with cholesteatoma].
Kuczkowski J; Kobierska-Gulida G; Izycka-Swieszewska E; Potocka M; Mikaszewski B; Sierszeń W
Otolaryngol Pol; 2010; 64(4):219-24. PubMed ID: 20873097
[TBL] [Abstract][Full Text] [Related]
10. Role of Langerhans cells, Ki-67 protein and apoptosis in acquired cholesteatoma: prospective clinical study.
Akdogan V; Yilmaz I; Canpolat T; Ozluoglu LN
J Laryngol Otol; 2013 Mar; 127(3):252-9. PubMed ID: 23331470
[TBL] [Abstract][Full Text] [Related]
11. The effect of BMP-2, BMP-4 and BMP-6 on bone destruction of cholesteatoma presence.
Oger M; Alpay HC; Orhan I; Onalan EE; Yanilmaz M; Sapmaz E
Am J Otolaryngol; 2013; 34(6):652-7. PubMed ID: 23927997
[TBL] [Abstract][Full Text] [Related]
12. Fascin expression in cholesteatoma: correlation with destruction of the ossicular chain and extent of disease.
Binnetoglu A; Sari M; Baglam T; Erbarut Seven I; Yumusakhuylu AC; Topuz MF; Batman C
Clin Otolaryngol; 2015 Aug; 40(4):335-40. PubMed ID: 25581788
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of the epithelium stroma interaction of acquired middle ear cholesteatoma in children and adults.
Welkoborsky HJ; Jacob RS; Hinni ML
Eur Arch Otorhinolaryngol; 2007 Aug; 264(8):841-8. PubMed ID: 17541620
[TBL] [Abstract][Full Text] [Related]
14. [Carcinoembryonic antigen in chronic otitis media with cholesteatoma].
Sanković-Babić S; Sofronić-Milosavljević Lj
Srp Arh Celok Lek; 2000; 128(3-4):80-3. PubMed ID: 10932614
[TBL] [Abstract][Full Text] [Related]
15. The functional and anatomical results of the canal wall down tympanoplasty in extensive cholesteatoma.
Aslan Felek S; Islam A; Celik H; Demirci M; Samim E; Kose SK
Acta Otolaryngol; 2009 Dec; 129(12):1388-94. PubMed ID: 19922086
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and pathological features of cholesteatoma in young children].
Skotnicka B; Hassmann-Poznańska E
Otolaryngol Pol; 2010; 64(6):375-81. PubMed ID: 21302505
[TBL] [Abstract][Full Text] [Related]
17. Using surgical observations of ossicular erosion patterns to characterize cholesteatoma growth.
Maresh A; Martins OF; Victor JD; Selesnick SH
Otol Neurotol; 2011 Oct; 32(8):1239-42. PubMed ID: 21921854
[TBL] [Abstract][Full Text] [Related]
18. Analysis of differences in facial nerve dehiscence and ossicular injury in chronic otitis media and cholesteatoma.
Choi SA; Kang HM; Byun JY; Park MS; Yeo SG
Acta Otolaryngol; 2014 May; 134(5):455-61. PubMed ID: 24702225
[TBL] [Abstract][Full Text] [Related]
19. The relationship between individual ossicular status and conductive hearing loss in cholesteatoma.
Martins O; Victor J; Selesnick S
Otol Neurotol; 2012 Apr; 33(3):387-92. PubMed ID: 22410730
[TBL] [Abstract][Full Text] [Related]
20. [Computed tomography (CT) of the temporal bone in diagnosis of acquired cholesteatoma of the middle ear].
Zelikovich EI
Vestn Otorinolaringol; 2004; (5):28-32. PubMed ID: 15602483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
